Serum visfatin in type 2 diabetes mellitus

• मुख्य लेखकों: Samiha A. Abd Rabo (लेखक), Nagwa A. Mohammed (लेखक), Somayh S. Eissa (लेखक), Abeer A. Ali (लेखक), Sahar M. Ismail (लेखक), Reham S. Gad (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: SpringerOpen, 2013-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

IntroductionObesity is commonly associated with insulin resistance and hyperinsulinemia and is the most important risk factor for type 2 diabetes. Visfatin is an adipokine that exerts insulin-mimetic effects that stimulate muscle and adipocyte glucose transport and inhibit hepatocyte glucose product...